IFNG and neoplasm: For example, in a mouse cancer model, treatment of mice with IFN-γ-blocking antibodies largely abolished PD-L1 expression on tumor cells but only partially reduced PD-L1 levels on tumor-associated macrophages (Noguchi et al., 2017).